DGX vs VATE · P/E 22, rev $5.94B vs rev $786.4M
Quest Diagnostics Incorporated (DGX) versus Innovate Corp (VATE) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Innovate Corp (VATE) is a engineering & construction company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported VATE revenue for 2026-06-30 was $786.4M. Net income was -$6.1M. VATE currently screens at market cap $226.3M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. VATE currently screens at market cap $226.3M.
Not investment advice. Open the DGX and VATE stock pages for the full models.
Not investment advice.